17
Dec
SGLT2 INHIBITORS TYPE OF ANTIDIABETIC DRUGS METHOD DEVELOPMENT AND VALIDATION: A STATE-OF-THE-ART REVIEW
Asmita V. Gaikwad1*, Preeti Khulbe2 Research Scholar, School of Pharmacy, Suresh Gyan Vihar University, Jaipur, Rajasthan, India. School of Pharmacy. Suresh Gyan Vihar University, Jaipur, Rajasthan, India. *Corresponding Author E-mail: asmitavgaikwad@gmail.com Abstract: Type 2 diabetes mellitus raises the risk of cardiovascular disease since it is a chronic metabolic infection (CVD). Glycosuria is a side effect